Virtual West Oncology Conference
Targeted Therapy for RET Fusion+ NSCLC: Efficacy Data for FDA Approved Selpercatinib & Pralsetinib
By
Virtual West Oncology Conference
FEATURING
Erminia Massarelli
By
Virtual West Oncology Conference
FEATURING
Erminia Massarelli
Login to view comments.
Click here to Login